Ignite Creation Date:
2025-12-24 @ 9:54 PM
Ignite Modification Date:
2026-02-28 @ 10:35 PM
Study NCT ID:
NCT05627232
Status:
SUSPENDED
Last Update Posted:
2025-11-03
First Post:
2022-11-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tazemetostat and Palbociclib With CPX-351for R/R AML
Sponsor:
Thomas Jefferson University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
22G.769
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER_GOV | View |